chr1-237445473-A-G
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 5P and 20B. PM1PM5PP2BP4_StrongBP6_Very_StrongBS1BS2
The NM_001035.3(RYR2):āc.1243A>Gā(p.Thr415Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000108 in 1,613,786 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T415I) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001035.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RYR2 | NM_001035.3 | c.1243A>G | p.Thr415Ala | missense_variant | 14/105 | ENST00000366574.7 | NP_001026.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RYR2 | ENST00000366574.7 | c.1243A>G | p.Thr415Ala | missense_variant | 14/105 | 1 | NM_001035.3 | ENSP00000355533.2 | ||
RYR2 | ENST00000609119.2 | n.1243A>G | non_coding_transcript_exon_variant | 14/104 | 5 | ENSP00000499659.2 | ||||
RYR2 | ENST00000660292.2 | c.1243A>G | p.Thr415Ala | missense_variant | 14/106 | ENSP00000499787.2 | ||||
RYR2 | ENST00000659194.3 | c.1243A>G | p.Thr415Ala | missense_variant | 14/105 | ENSP00000499653.3 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152214Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000137 AC: 34AN: 249060Hom.: 0 AF XY: 0.000185 AC XY: 25AN XY: 135108
GnomAD4 exome AF: 0.000112 AC: 163AN: 1461454Hom.: 0 Cov.: 30 AF XY: 0.000171 AC XY: 124AN XY: 727006
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152332Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74482
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 26, 2019 | The p.Thr415Ala variant in RYR2 is classified as likely benign because it has been identified in 0.11% (34/30602) of East Asian chromosomes by gnomAD (http://gnomad.broadinstitute.org). ACMG/AMP Criteria applied: BS1. - |
Cardiomyopathy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | May 05, 2019 | This missense variant replaces threonine with alanine at codon 415 of the RYR2 protein. Computational prediction tools and conservation analyses are inconclusive regarding the impact of this variant on the protein function. Computational splicing tools suggest that this variant may not impact RNA splicing. To our knowledge, functional assays have not been performed for this variant nor has the variant been reported in individuals affected with cardiovascular disease in the literature. This variant has been identified in 34/30602 South Asian chromosomes (0.11%) in the general population by the Genome Aggregation Database (gnomAD). This variant allele frequency is greater than expected for disease based on prevalence, penetrance, and genetic heterogeneity. Based on available evidence, this variant is classified as Likely Benign. - |
Catecholaminergic polymorphic ventricular tachycardia 1 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 21, 2023 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 03, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at